ZYLOX Unicorn™ Vascular Closure Device Receives Regulatory Approval in Indonesia
HANGZHOU, China, May 26, 2025 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. ('Zylox-Tonbridge' or the 'Company') today announced that its proprietary ZYLOX Unicorn™ Vascular Closure Device (VCD) has received regulatory approval in Indonesia. This marks the ZYLOX Unicorn™ Vascular Closure Device's first international market clearance and the Company's first market authorization in Southeast Asia—representing a significant step forward in its international expansion strategy.
As China's first domestically developed vascular closure device, the ZYLOX Unicorn™ VCD offers an extended closure range from 5F to 22F and is compatible with large-bore access sites (≥8F), enabling broader clinical applications and addressing previously unmet needs in vascular intervention. Designed to meet global standards, the ZYLOX Unicorn™ VCD has demonstrated strong safety and efficacy in premarket clinical trials. The system facilitates effective vascular closure, shortens patient immobilization time, and reduces the risk of puncture-site complications—delivering high-quality, affordable care to a wider patient population. The product was granted marketing authorization in China in June 2024.
Indonesia, the world's fourth most populous country, represents a major opportunity for expanding access to advanced vascular intervention solutions. The approval of the ZYLOX Unicorn™ VCD in this key market will provide local physicians and patients with greater access to comprehensive vascular intervention solutions and support Zylox-Tonbridge's continued expansion across Southeast Asia.
Zylox-Tonbridge's overseas business has grown rapidly in recent years, generating approximately USD 3.1 million in revenue in 2024, with a four-year compound annual growth rate (CAGR) of 87%. The Company's business footprint spans Europe, the Americas, the Middle East, and Africa, covering countries such as France, Germany, Italy, Spain, Turkey, Saudi Arabia, Argentina, Brazil, and South Africa. In 2025, Zylox-Tonbridge showcased key products at major global congresses including LINC, PAIRS, CICE, and ESOC, boosting its international brand visibility.
Looking ahead, Zylox-Tonbridge remains committed to its mission of 'Innovation for Quality Life' and will continue expanding global access to high-quality, affordable treatment solutions through enhanced localization and strategic market entry.
View original content: https://www.prnewswire.com/news-releases/zylox-unicorn-vascular-closure-device-receives-regulatory-approval-in-indonesia-302465436.html
SOURCE ZYLOX-TONBRIDGE
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Social Security may run dry earlier than previously anticipated, trustees say
The trust funds for Social Security and Medicaid will run out of money in as little as 8 years, a shorter time frame than previously estimated, according to a report issued Wednesday by the programs' trustees. The Social Security fund will run dry in 2033, unless Congress combines the program's old-age and disability funds, in which case insolvency would arrive in 2034, the report found. A finding last year predicted Social Security would become insolvent in 2035 or 2036. Medicare's hospital insurance fund is expected to run out of money in 2033, the report said. MORE: Trump admin live updates: Trump to delay TikTok ban for 3rd time 'Social Security and Medicare are vital programs that support tens of millions of Americans across the country,' U.S. Secretary of Treasury Scott Bessent said in a statement. 'This data underscores the need for lawmakers to take action to support the long-term viability of these programs.' If Congress fails to address the projected budget shortfalls, automatic cuts will dial back Social Security benefits by 23% and Medicare hospital benefits by 11% in 2033, the report found. Roughly 66 million Americans receive medical coverage through Medicare, while 70 million people are set to receive Social Security benefits this year. The Social Security and Medicare trust funds generate revenue through a payroll tax paid by employees and employers, setting the income apart from the overall federal budget. The programs routinely spend more money than they take in through such taxes. President Donald Trump has vowed to safeguard Social Security and Medicare, even as the White House pursues spending cuts at other federal programs and agencies. The Department of Government Agency, formerly led by Elon Musk, sought to eliminate what it described as 'waste, fraud and abuse' in Social Security and Medicare. In March, the White House backed such efforts in a memo. MORE: Fed holds interest rates steady, defying Trump Last year, the Government Accountability Office, a federal agency, estimated that taxpayers lose as much as $521 billion annually to fraud, much of which occurs in entitlement programs like Medicare. The Centers for Medicare and Medicaid Services (CMS) have stopped more than $100 billion in potentially fraudulent expenditures over recent months, the agency said in a statement. Still, those possible savings make up a fraction of roughly $1.9 trillion in spending for Medicare and Medicaid in 2023, the most recent year for which data is available. 'Medicare provides essential coverage for millions of American seniors, but this year's report underscores the urgent need for serious, sustained reform to secure its long-term future,' CMS Administrator Mehmet Oz said in a statement.
Bloomberg
an hour ago
- Bloomberg
Korea's Cuckoo Set for Malaysia Debut After Scaling Down IPO
A subsidiary of South Korean home-appliance maker Cuckoo Holdings Co. is set to go public in Malaysia after a scaled-down offering that's expected to raise 395 million ringgit ($93 million). Cuckoo International (Mal) Bhd. will begin trading on June 24, two months after postponing Bloomberg Terminal its initial public offering due to market volatility. The final amount raised may vary as the company is waiting for approval from the bourse to reduce its public shareholding spread to 20% from the current 25%.
Bloomberg
an hour ago
- Bloomberg
Malaysia FX Reserves at Three-Year High to Aid Ringgit Stability
Malaysia's increasing currency reserves are bolstering its defenses against market volatility. The country's net foreign exchange reserves rose to $94.7 billion at the end of April, according to the latest central bank data, the most since June 2022. Strong foreign inflows into local bonds and a weaker greenback, which enabled Bank Negara Malaysia to unwind its net short forward FX position, both helped. These factors have strengthened the nation's bulwark against external shocks.
